NO955197L - Nye carbosykliske nukleoside midler som er anvendbare som selektive inhibitorer av pro-inflammatoriske cytokiner - Google Patents

Nye carbosykliske nukleoside midler som er anvendbare som selektive inhibitorer av pro-inflammatoriske cytokiner

Info

Publication number
NO955197L
NO955197L NO955197A NO955197A NO955197L NO 955197 L NO955197 L NO 955197L NO 955197 A NO955197 A NO 955197A NO 955197 A NO955197 A NO 955197A NO 955197 L NO955197 L NO 955197L
Authority
NO
Norway
Prior art keywords
pro
inflammatory cytokines
agents useful
selective inhibitors
alkyl
Prior art date
Application number
NO955197A
Other languages
English (en)
Other versions
NO955197D0 (no
NO312836B1 (no
Inventor
Iii Carl Keith Edwards
David Roger Borcherding
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO955197D0 publication Critical patent/NO955197D0/no
Publication of NO955197L publication Critical patent/NO955197L/no
Publication of NO312836B1 publication Critical patent/NO312836B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19955197A 1993-06-21 1995-12-20 Forbindelser anvendelige som selektive inhibitorer av pro- inflammatoriske cytokiner og farmasöytisk preparat inneholdendenevnte forbindelser NO312836B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8024993A 1993-06-21 1993-06-21
PCT/US1994/005916 WO1995000514A1 (en) 1993-06-21 1994-05-25 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines

Publications (3)

Publication Number Publication Date
NO955197D0 NO955197D0 (no) 1995-12-20
NO955197L true NO955197L (no) 1996-02-16
NO312836B1 NO312836B1 (no) 2002-07-08

Family

ID=22156170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19955197A NO312836B1 (no) 1993-06-21 1995-12-20 Forbindelser anvendelige som selektive inhibitorer av pro- inflammatoriske cytokiner og farmasöytisk preparat inneholdendenevnte forbindelser

Country Status (20)

Country Link
US (1) US6541482B2 (no)
EP (1) EP0705263B1 (no)
JP (1) JP3479077B2 (no)
KR (1) KR100337720B1 (no)
CN (1) CN1041631C (no)
AT (1) ATE151423T1 (no)
AU (1) AU677851B2 (no)
CA (1) CA2165779C (no)
DE (1) DE69402548T2 (no)
DK (1) DK0705263T3 (no)
ES (1) ES2103131T3 (no)
FI (1) FI956142A0 (no)
GR (1) GR3023373T3 (no)
HU (1) HUT73412A (no)
IL (1) IL110041A0 (no)
NO (1) NO312836B1 (no)
NZ (1) NZ267322A (no)
TW (1) TW356471B (no)
WO (1) WO1995000514A1 (no)
ZA (1) ZA944256B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111497D0 (en) * 2001-05-11 2001-07-04 Medical Res Council Therapeutic methods
GB0114286D0 (en) * 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
WO2004056868A2 (en) * 2002-12-19 2004-07-08 Endocube Sas Nf-hev compositions and methods of use
US7196093B2 (en) 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7868011B2 (en) * 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US7517887B2 (en) 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
US11033821B2 (en) 2003-09-02 2021-06-15 Jeffrey D. Mullen Systems and methods for location based games and employment of the same on location enabled devices
CA2569016C (en) * 2004-06-02 2012-11-27 Takeda Pharmaceutical Company Limited Fused heterocyclic compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN164556B (no) 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
US4916224A (en) 1988-01-20 1990-04-10 Regents Of The University Of Minnesota Dideoxycarbocyclic nucleosides
US4931559A (en) 1988-01-20 1990-06-05 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
AU642526B2 (en) 1990-09-14 1993-10-21 Marion Merrell Dow Inc. Method of immunosuppression using cyclopentenyl substituted nucleoside analogs and compositions thereof
AU647822B2 (en) * 1990-09-14 1994-03-31 Marion Merrell Dow Inc. Novel carbocyclic adenosine analogs useful as immunosuppressants
US5332814A (en) * 1991-11-12 1994-07-26 Ciba-Geigy Corporation Process for the preparation of carbacyclic nucleosides, and intermediates
AU658698B2 (en) 1991-12-06 1995-04-27 Aventis Pharmaceuticals Inc. Novel trans cyclopentanyl purine analogs useful as immunosuppressants
GB9204015D0 (en) * 1992-02-25 1992-04-08 Wellcome Found Therapeutic nucleosides
SK285229B6 (sk) * 1997-05-13 2006-09-07 Lonza Ag Spôsob výroby derivátov (1R,4S)- alebo (1S,4R)-1-amino-4- (hydroxymetyl)-2-cyklopenténu a enantioméru (1R,4S)-N-butyryl-1- amino-4-(hydroxymetyl)-2-cyklopenténu
JPH11255768A (ja) * 1998-03-09 1999-09-21 Ajinomoto Co Inc 抗ウイルス剤の製造方法

Also Published As

Publication number Publication date
CA2165779A1 (en) 1995-01-05
TW356471B (en) 1999-04-21
EP0705263A1 (en) 1996-04-10
NO955197D0 (no) 1995-12-20
ZA944256B (en) 1995-02-08
JPH08511558A (ja) 1996-12-03
HU9503689D0 (en) 1996-02-28
DE69402548D1 (de) 1997-05-15
HUT73412A (en) 1996-07-29
AU677851B2 (en) 1997-05-08
FI956142A (fi) 1995-12-20
IL110041A0 (en) 1994-10-07
EP0705263B1 (en) 1997-04-09
NZ267322A (en) 1997-09-22
WO1995000514A1 (en) 1995-01-05
FI956142A0 (fi) 1995-12-20
NO312836B1 (no) 2002-07-08
JP3479077B2 (ja) 2003-12-15
CA2165779C (en) 1998-06-16
GR3023373T3 (en) 1997-08-29
ATE151423T1 (de) 1997-04-15
CN1125946A (zh) 1996-07-03
ES2103131T3 (es) 1997-08-16
KR100337720B1 (ko) 2002-11-02
CN1041631C (zh) 1999-01-13
DE69402548T2 (de) 1997-07-17
AU6958394A (en) 1995-01-17
KR960703122A (ko) 1996-06-19
US6541482B2 (en) 2003-04-01
DK0705263T3 (da) 1997-05-05
US20020004508A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
HUP0001446A2 (hu) HIV reverz transzkriptáz inhibitor hatású 4,4-diszubsztituált-3,4-dihidro-2(1H)-kinazolinon-származékok, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
TW370529B (en) Pyrazolopyrimidines
HUP0101031A2 (hu) Biciklo[2.2.1]heptán-származékok és rokon vegyületek
ES2188280T3 (es) Acetales heteroaril-ciclicos.
HUP0004221A2 (hu) O-Helyettesített hidroxi-kumaranon-származékok, alkalmazásuk tumor- és metasztázis-ellenes gyógyszerkészítmények előállítására és a gyógyszerkészítmények
DK0686142T3 (da) Polyaminderivater som radioprotektive midler
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
NO964698D0 (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
NO955197L (no) Nye carbosykliske nukleoside midler som er anvendbare som selektive inhibitorer av pro-inflammatoriske cytokiner
HUP0303449A2 (hu) Szubsztituált benzofurán-2-karboxamid-származékok
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
HUP0001010A2 (hu) Benzimidazol-származékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
HUP9900246A2 (hu) Liofilizált tio-xantenont tartalmazó tumorellenes gyógyszerkészítmények
ZA979331B (en) Pharmaceutical compounds.
DE69826034D1 (de) 1,2-dihydro-2-oxochinolin-derivate
MY131365A (en) Carbamic acid derivatives
FI955680A (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
RU94031211A (ru) Производные изатина, способ их получения и фармацевтическая композиция на их основе
TH18165A (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล